Sylvie Kirscher

442 total citations
13 papers, 168 citations indexed

About

Sylvie Kirscher is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Sylvie Kirscher has authored 13 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Sylvie Kirscher's work include Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Breast Cancer Treatment Studies (3 papers). Sylvie Kirscher is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Breast Cancer Treatment Studies (3 papers). Sylvie Kirscher collaborates with scholars based in France and Belgium. Sylvie Kirscher's co-authors include B. Chauvet, F Reboul, Y. Brewer, F. Rétornaz, Dominique Genet, Éléna Paillaud, Julien Taı̈eb, Thierry Lecomte, Laurent Bedenne and Étienne Brain and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Critical Reviews in Oncology/Hematology.

In The Last Decade

Sylvie Kirscher

12 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sylvie Kirscher France	6	103	74	39	33	18	13	168
Mélanie Dore France	9	47 0.5×	140 1.9×	27 0.7×	19 0.6×	7 0.4×	17	208
Francesco Cortiula Italy	10	202 2.0×	170 2.3×	48 1.2×	6 0.2×	21 1.2×	38	324
Susann Theile Denmark	9	207 2.0×	55 0.7×	31 0.8×	13 0.4×	7 0.4×	26	303
Athanasios Karampeazis Greece	10	245 2.4×	221 3.0×	20 0.5×	25 0.8×	15 0.8×	26	317
Lionel Uwer France	6	140 1.4×	56 0.8×	38 1.0×	19 0.6×	8 0.4×	14	189
Regina Gironés Sarrió Spain	6	81 0.8×	73 1.0×	17 0.4×	16 0.5×	17 0.9×	28	161
Mathieu Baconnier France	6	106 1.0×	45 0.6×	20 0.5×	13 0.4×	29 1.6×	15	130
Emanuele Romairone Italy	10	140 1.4×	40 0.5×	32 0.8×	62 1.9×	24 1.3×	25	269
Ali Abdulnabi Suwaidan United Kingdom	8	118 1.1×	52 0.7×	42 1.1×	8 0.2×	25 1.4×	13	234
Edith Perez United States	3	122 1.2×	100 1.4×	89 2.3×	15 0.5×	43 2.4×	3	214

Countries citing papers authored by Sylvie Kirscher

Since Specialization

Citations

This map shows the geographic impact of Sylvie Kirscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Kirscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Kirscher more than expected).

Fields of papers citing papers by Sylvie Kirscher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Kirscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Kirscher. The network helps show where Sylvie Kirscher may publish in the future.

Co-authorship network of co-authors of Sylvie Kirscher

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Kirscher. A scholar is included among the top collaborators of Sylvie Kirscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Kirscher. Sylvie Kirscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Brain, Étienne, Emmanuelle Bourbouloux, Olivier Rigal, et al.. (2022). Final results from a phase III randomized clinical trial of adjuvant endocrine therapy ± chemotherapy in women ≥ 70 years old with ER+ HER2- breast cancer and a high genomic grade index: The Unicancer ASTER 70s trial.. Journal of Clinical Oncology. 40(16_suppl). 500–500. 16 indexed citations

Ninot, Grégory, P. Debourdeau, Gaëtan De Rauglaudre, et al.. (2018). Pour des soins de support de l’après cancer. Bulletin du Cancer. 105(9). 763–770. 2 indexed citations

Aparicio, Thomas, Olivier Bouché, Julien Taı̈eb, et al.. (2017). Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results. Annals of Oncology. 29(1). 133–138. 50 indexed citations

Aparicio, Thomas, O. Bouché, Éric François, et al.. (2016). Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20. Annals of Oncology. 27. vi194–vi194. 1 indexed citations

Aparicio, Thomas, Olivier Bouché, Éric François, et al.. (2015). PRODIGE 20: Bevacizumab + chemotherapy (BEV-CT) versus chemotherapy alone (CT) in elderly patients (pts) with untreated metastatic colorectal cancer (mCRC)—A randomized phase II trial.. Journal of Clinical Oncology. 33(15_suppl). 3541–3541. 6 indexed citations

Dubot, Coraline, Emmanuelle Bourbouloux, Olivier Mir, et al.. (2014). ASTER 70s UNICANCER phase III Trial: Can a genomic prognosticator help tailoring adjuvant systemic treatment for luminal breast carcinoma in elderly women?. Journal of Geriatric Oncology. 5. S28–S28. 1 indexed citations

Kirscher, Sylvie, et al.. (2012). Informatisation du circuit des pompes patients controled analgesia (PCA) dans un établissement de soins carcinologiques. Douleurs Évaluation - Diagnostic - Traitement. 13. A66–A67.

Brain, Étienne, C. Mertens, Véronique Girre, et al.. (2010). Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial. Critical Reviews in Oncology/Hematology. 80(1). 160–170. 38 indexed citations

Mineur, Laurent, et al.. (2010). Are we turning to more than a first line treatment of metastatic colorectal cancer with high dose irinotecan ?: A monocentric institution safety analysis of 46 patients. Clinics and Research in Hepatology and Gastroenterology. 35(2). 125–131. 5 indexed citations

10.

Nahon, Stéphane, et al.. (2001). [Axillary lymph node and bone marrow micrometastases of breast cancer].. PubMed. 88(11). 1095–104. 1 indexed citations

11.

Berger, Christine, Sylvie Kirscher, B. Chauvet, et al.. (1998). Radiochimiothérapie concomitante préopératoire pour cancer du rectum. Cancer/Radiothérapie. 2(3). 260–265. 5 indexed citations

12.

Serin, Daniel, Sylvie Kirscher, Y. Brewer, et al.. (1997). [Adjuvant combined radiochemotherapy: a feasibility study of a new strategy in stages I and II].. PubMed. 84(3). 247–53. 9 indexed citations

13.

Chauvet, B., et al.. (1994). Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy.. Journal of Clinical Oncology. 12(7). 1402–1407. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact